U.S. Capital Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.37M Buy
20,942
+841
+4% +$300K 0.19% 128
2025
Q4
$6.58M Buy
20,101
+768
+4% +$244K 0.17% 147
2025
Q3
$5.46M Buy
19,333
+177
+0.9% +$51.3K 0.15% 167
2025
Q2
$5.35M Buy
19,156
+1,385
+8% +$392K 0.16% 153
2025
Q1
$5.54M Buy
17,771
+1,291
+8% +$381K 0.17% 147
2024
Q4
$4.3M Sell
16,480
-5,561
-25% -$1.65M 0.13% 168
2024
Q3
$7.1M Buy
22,041
+256
+1% +$83.7K 0.25% 90
2024
Q2
$6.81M Buy
21,785
+89
+0.4% +$26.1K 0.26% 89
2024
Q1
$6.17M Buy
21,696
+4,931
+29% +$1.44M 0.24% 100
2023
Q4
$4.83M Sell
16,765
-3,684
-18% -$1M 0.19% 123
2023
Q3
$5.5M Sell
20,449
-98
-0.5% -$24.5K 0.25% 90
2023
Q2
$4.56M Buy
20,547
+143
+0.7% +$33.2K 0.22% 107
2023
Q1
$4.93M Buy
20,404
+761
+4% +$187K 0.23% 99
2022
Q4
$5.16M Sell
19,643
-400
-2% -$107K 0.24% 93
2022
Q3
$4.52M Buy
20,043
+2,073
+12% +$502K 0.23% 96
2022
Q2
$4.37M Sell
17,970
-41
-0.2% -$10K 0.19% 113
2022
Q1
$4.36M Sell
18,011
-11,527
-39% -$2.65M 0.16% 133
2021
Q4
$6.64M Sell
29,538
-2,035
-6% -$430K 0.26% 86
2021
Q3
$6.71M Buy
+31,573
New +$7.27M 0.29% 84

Other funds holding AMGN

U.S. Capital Wealth Advisors's AMGN Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Amgen (AMGN) stake by 4.2% in Q1 2026, buying an estimated $300K and bringing the position to 20,942 shares worth $7.37M. The position accounts for 0.19% of the portfolio, ranked #128.

U.S. Capital Wealth Advisors first reported a position in AMGN in Q3 2021 and has held it in 19 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • U.S. Capital Wealth Advisors held 20,942 shares of Amgen worth $7.37M as of Q1 2026.
  • U.S. Capital Wealth Advisors bought 841 Amgen shares in Q1 2026, an estimated $300K.
  • Amgen made up 0.19% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #128 holding.
  • U.S. Capital Wealth Advisors first reported a position in Amgen in Q3 2021 and has held it in 19 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.